The Type 1 Interleukin-1 Receptor Is Essential for the Efficient Activation of Microglia and the Induction of Multiple Proinflammatory Mediators in Response to Brain Injury
Open Access
- 15 July 2002
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 22 (14) , 6071-6082
- https://doi.org/10.1523/jneurosci.22-14-06071.2002
Abstract
Interleukin-1 (IL-1) is induced immediately after insults to the brain, and elevated levels of IL-1 have been strongly implicated in the neurodegeneration that accompanies stroke, Alzheimer's disease, and multiple sclerosis. In animal models, antagonizing IL-1 has been shown to reduce cell death; however, the basis for this protection has not been elucidated. Here we analyzed the response to penetrating brain injury in mice lacking the type 1 IL-1 receptor (IL-1R1) to determine which cellular and molecular mediators of tissue damage require IL-1 signaling. At the cellular level, fewer amoeboid microglia/macrophages appeared adjacent to the injured brain tissue in IL-1R1 null mice, and those microglia present at early postinjury intervals retained their resting morphology. Astrogliosis also was mildly abrogated. At the molecular level, cyclooxygenase-2 (Cox-2) and IL-6 expression were depressed and delayed. Interestingly, basal levels of Cox-2, IL-1, and IL-6 were significantly lower in the IL-1R1 null mice. In addition, stimulation of vascular cell adhesion molecule-1 mRNA was depressed in the IL-1R1 null mice, and correspondingly, there was reduced diapedesis of peripheral macrophages in the IL-1R1 null brain after injury. This observation correlated with a reduced number of Cox-2+amoeboid phagocytes adjacent to the injury. In contrast, several molecular aspects of the injury response were normal, including expression of tumor necrosis factor-α and the production of nerve growth factor. Because antagonizing IL-1 protects neural cells in experimental models of stroke and multiple sclerosis, our data suggest that cell preservation is achieved by abrogating microglial/macrophage activation and the subsequent self-propagating cycle of inflammation.Keywords
This publication has 51 references indexed in Scilit:
- Interleukin 1 in the brain: biology, pathology and therapeutic targetTrends in Neurosciences, 2000
- Interleukin-1 Receptor Type I Gene-Deficient Mice Are Less Susceptible toStaphylococcus epidermidisBiomaterial-Associated Infection than Are Wild-Type MiceInfection and Immunity, 2000
- Acute Exposure to CNTFin VivoInduces Multiple Components of Reactive GliosisExperimental Neurology, 1996
- Neuroprotective Effects of Human Recombinant Interleukin-1 Receptor Antagonist in Focal Cerebral Ischaemia in the RatJournal of Cerebral Blood Flow & Metabolism, 1996
- Interleukin-1 as a Pathogenetic Mediator of Ischemic Brain Damage in RatsStroke, 1995
- Upregulation of Nerve Growth Factor Following Cortical TraumaExperimental Neurology, 1994
- Postischemic administration of an anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats.Stroke, 1994
- The immortalized astroglial cell line RC7 is a new model system for the study of nerve growth factor (NGF) regulation: Stimulation by interleukin‐1β and transforming growth factor‐β1 is additive and affected differently by dibutyryl cyclic AMPGlia, 1994
- Regional and cellular codistribution of interleukin 1 beta and nerve growth factor mRNA in the adult rat brain: possible relationship to the regulation of nerve growth factor synthesis.The Journal of cell biology, 1990
- Interleukin-1 β and tumor necrosis factor-α synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytesNeuroscience Letters, 1990